BIO NANO HOLDINGS LIMITED - Filleted accounts

BIO NANO HOLDINGS LIMITED - Filleted accounts


Registered number
09188375
BIO NANO HOLDINGS LIMITED
Filleted Accounts
28 February 2017
BIO NANO HOLDINGS LIMITED
Registered number: 09188375
Balance Sheet
as at 28 February 2017
Notes 2017 2016
£ £ £ £
Fixed assets
Intangible assets 2 3,590 4,600
Current assets
Debtors 3 - 411
Cash at bank and in hand 510 23,466
510 23,877
Creditors: amounts falling due within one year 4 (25,182) (46,768)
Net current liabilities (24,672) (22,891)
Net liabilities (21,082) (18,291)
Capital and reserves
Called up share capital 20 20
Profit and loss account (21,102) (18,311)
Shareholders' funds (21,082) (18,291)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
D F Sarphie
Director
Approved by the board on 3 November 2017
BIO NANO HOLDINGS LIMITED
Notes to the Accounts
for the year ended 28 February 2017
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Consolidated accounts
Consolidated accounts have not been prepared as the company is subject to the provisions of the small companies regime.
Intellectual property
The costs associated with the application for patents and trademarks are capitalised and amortised on a straight line basis at 20% per annum, this being the directors’ prudent estimate of the economic life of the intellectual property acquired. Patent renewal costs are written off as incurred.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
2 Intangible fixed assets £
Patent Costs:
Cost
At 1 March 2016 5,050
At 28 February 2017 5,050
Amortisation
At 1 March 2016 450
Provided during the year 1,010
At 28 February 2017 1,460
Net book value
At 28 February 2017 3,590
At 29 February 2016 4,600
3 Debtors 2017 2016
£ £
Other debtors - 411
4 Creditors: amounts falling due within one year 2017 2016
£ £
Trade creditors - 2,465
Amounts owed to group undertakings and undertakings in which the company has a participating interest 24,782 43,503
Other creditors 400 800
25,182 46,768
5 Subsidiary undertaking
The company is the sole member of The Bio Nano Centre Limited, a company incorporated in England and Wales and limited by guarantee.
6 Controlling party
The company is under the control of the directors.
7 Other information
BIO NANO HOLDINGS LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
338 Euston Road
London
NW1 3BT
BIO NANO HOLDINGS LIMITED 09188375 false 2016-03-01 2017-02-28 2017-02-28 VT Final Accounts September 2017 D F Sarphie No description of principal activity 09188375 core:WithinOneYear 2016-02-29 09188375 core:ShareCapital 2016-02-29 09188375 core:RetainedEarningsAccumulatedLosses 2016-02-29 09188375 2016-03-01 2017-02-28 09188375 bus:PrivateLimitedCompanyLtd 2016-03-01 2017-02-28 09188375 bus:AuditExempt-NoAccountantsReport 2016-03-01 2017-02-28 09188375 bus:Director40 2016-03-01 2017-02-28 09188375 core:Goodwill 2016-03-01 2017-02-28 09188375 countries:England 2016-03-01 2017-02-28 09188375 bus:FRS102 2016-03-01 2017-02-28 09188375 bus:FullAccounts 2016-03-01 2017-02-28 09188375 2017-02-28 09188375 core:WithinOneYear 2017-02-28 09188375 core:ShareCapital 2017-02-28 09188375 core:RetainedEarningsAccumulatedLosses 2017-02-28 09188375 core:Goodwill 2017-02-28 09188375 2016-02-29 09188375 core:Goodwill 2016-02-29 iso4217:GBP